AGP Executive Report
Last update: 7 hours agoIndustry Shake-up: Organigram agreed to acquire Aurora Cannabis for C$561 million, topping Curaleaf’s hostile bid. The deal combines Aurora’s international medical cannabis network with Organigram’s Canadian and European operations. U.S. Regulation: The American Medical Association urged the FDA to apply drug-level scientific standards to cannabis and other botanical products, citing concerns about safety research as products grow more potent. Separately, the DEA granted federal registrations to more than 900 medical cannabis dispensaries, though reports say adult-use states were excluded. Global Markets: Costa Rica’s medical cannabis industry has reached EU-audited cultivation, licensed THC manufacturing and its first shipment to Europe, but pharmacy access for patients remains unresolved. Enforcement: Nigerian Customs said it seized 3.4 tonnes of cannabis in a four-week South-West crackdown, among other contraband.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
